Marco Saponaro
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Marco Saponaro has a total of 145 co-authors. Here are the top co-authors by number of shared publications:
Jianming Wang
Department of Cancer and Genomic Sciences, School of Medical Sciences, College of Medicine and Health, University of Birmingham, Birmingham B15 2TT, UK
6 shared publications- Gavin Kelly
Bioinformatics and Biostatistics, The Francis Crick Institute, London, UK
4 shared publications - Jesper Qualmann Svejstrup
Centre for Gene Expression, Department of Cellular and Molecular Medicine, University of Copenhagen, Blegdamsvej 3B, 220 Copenhagen, Denmark
4 shared publications - Aengus Stewart
Bioinformatics and Biostatistics, The Francis Crick Institute, 1 Midland Road, London NW1 1AT, UK
3 shared publications - Giordano Liberi
Dipartimento di Genetica e di Biologia dei Microrganismi, Università degli Studi di Milano, Via Celoria 26, 20133 Milan, Italy
3 shared publications Martina Muste Sadurni
Birmingham Centre for Genome Biology, University of Birmingham Department of Cancer and Genomic Sciences Birmingham, B15 2TT
3 shared publications
Latest Publications
- Open Access
ATR activity regulates DNA replication and RNA polymerase II transcription during S-phase
- Open Access
- 8 July 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (13)
CDK-driven phosphorylation of TRAIP is essential for mitotic replisome disassembly and MiDAS
Disassembly of the replication machinery (replisome) from chromatin is an active process driven by two ubiquitin ligases Cul2LRR1 and TRAIP, which both target the Mcm7 subunit of the replicative helicase for ubiquitylation. Uncontrolled unloading of replisomes during S-phase would be disastrous for genome stability and cell viability. On the other hand, replisomes retained on under-replicated DNA in mitosis require removal to allow access and processing of the DNA before cell division. TRAIP ubiquitylates replisomes in mitosis but can also act in specific situations during S-phase. However, we do not know how TRAIP’s activity is regulated to stop uncontrolled replisome unloading. Here we show that TRAIP activity towards replisomes is not regulated at the level of interaction with the substrate: it interacts with terminated replisomes in S-phase without ubiquitylation. However, in mitosis, TRAIP is phosphorylated by cyclin-dependent kinases (CDKs) and this phosphorylation is essential for mitotic replisome unloading. CDK phosphorylation of TRAIP stimulates its autoubiquitylation activity and ubiquitylation of replisomes isolated from mitotic chromatin. The phosphorylation of TRAIP is also important in human cells for TRAIP functions during MiDAS. Although essential during mitosis, the CDK-driven phosphorylation of TRAIP is not sufficient to activate uncontrolled unloading of replisomes in S-phase.
- 8 July 2025
- Published by Oxford University Press (OUP) in Nucleic Acids Research
- Vol. 53 (13)
Open AccessCDK-driven phosphorylation of TRAIP is essential for mitotic replisome disassembly and MiDAS
Disassembly of the replication machinery (replisome) from chromatin is an active process driven by two ubiquitin ligases Cul2LRR1 and TRAIP, which both target the Mcm7 subunit of the replicative helicase for ubiquitylation. Uncontrolled unloading of replisomes during S-phase would be disastrous for genome stability and cell viability. On the other hand, replisomes retained on under-replicated DNA in mitosis require removal to allow access and processing of the DNA before cell division. TRAIP ubiquitylates replisomes in mitosis but can also act in specific situations during S-phase. However, we do not know how TRAIP’s activity is regulated to stop uncontrolled replisome unloading. Here we show that TRAIP activity towards replisomes is not regulated at the level of interaction with the substrate: it interacts with terminated replisomes in S-phase without ubiquitylation. However, in mitosis, TRAIP is phosphorylated by cyclin-dependent kinases (CDKs) and this phosphorylation is essential for mitotic replisome unloading. CDK phosphorylation of TRAIP stimulates its autoubiquitylation activity and ubiquitylation of replisomes isolated from mitotic chromatin. The phosphorylation of TRAIP is also important in human cells for TRAIP functions during MiDAS. Although essential during mitosis, the CDK-driven phosphorylation of TRAIP is not sufficient to activate uncontrolled unloading of replisomes in S-phase.
- Open Access
MYBL2 maintains stemness and promotes theta-mediated end joining in triple negative breast cancer
Triple negative breast cancer (TNBC) has a poor prognosis due to limited treatment options and high metastasis risk. Breast cancer (BC) stem/progenitor cells, also known as tumour initiating cells, are a small, difficult to target population within the tumour responsible for metastasis and therapy resistance. MYBL2 overexpression is commonly linked to poor prognosis and metastasis but its role in BC stem/progenitor cells remains elusive. To determine the role of MYBL2 in BC stem/progenitor cells we generated TNBC cell lines with inducible MYBL2 downregulation. Our findings reveal that elevated MYBL2 is essential for self-renewal, DNA repair, and replication stress response in these cells and lowering MYBL2 impairs stemness and self-renewal both in vitro and in vivo . Accordingly, our functional and mechanistic analyses indicate that high-MYBL2 stem/progenitor cells exhibit increased sensitivity to Polθ inhibitors which is lost upon MYBL2 downregulation due to transcriptional suppression. Combining Polθ inhibitors with ATR inhibitors further enhances this sensitivity, in vitro and ex vivo. This study thus identifies Polθ/ATR inhibition as a synthetic lethality strategy to eradicate BC stem/progenitor cells and underscores MYBL2 expression as a biomarker for patient stratification in this treatment.
Open AccessMYBL2 maintains stemness and promotes theta-mediated end joining in triple negative breast cancer
Triple negative breast cancer (TNBC) has a poor prognosis due to limited treatment options and high metastasis risk. Breast cancer (BC) stem/progenitor cells, also known as tumour initiating cells, are a small, difficult to target population within the tumour responsible for metastasis and therapy resistance. MYBL2 overexpression is commonly linked to poor prognosis and metastasis but its role in BC stem/progenitor cells remains elusive. To determine the role of MYBL2 in BC stem/progenitor cells we generated TNBC cell lines with inducible MYBL2 downregulation. Our findings reveal that elevated MYBL2 is essential for self-renewal, DNA repair, and replication stress response in these cells and lowering MYBL2 impairs stemness and self-renewal both in vitro and in vivo . Accordingly, our functional and mechanistic analyses indicate that high-MYBL2 stem/progenitor cells exhibit increased sensitivity to Polθ inhibitors which is lost upon MYBL2 downregulation due to transcriptional suppression. Combining Polθ inhibitors with ATR inhibitors further enhances this sensitivity, in vitro and ex vivo. This study thus identifies Polθ/ATR inhibition as a synthetic lethality strategy to eradicate BC stem/progenitor cells and underscores MYBL2 expression as a biomarker for patient stratification in this treatment.
- Open Access
RNA Polymerase II subunits overexpressions induce genome instability and deregulate transcription
Independently of the pathways or circuits deregulated in cancer cells, these present altered transcription patterns, often also direct consequence of deregulation of transcription factors. In this sense, also the RNA Polymerase complexes responsible for transcription can be affected in cancers. We find that upregulations of RNA Polymerase II subunits, especially the largest ones, correlates with poor cancer patients’ outcome across a range of tumor types, presenting increased genome instability. Overexpressing the subunits RPB1, RPB3 and RPB4 in cells we find that these induce DNA damage. However, the mechanisms behind this increased genome instability are specific for each subunit, linked to the unique transcription alterations generated by the subunit overexpression. Importantly, we find significant overlap between the genes with more DNA damage in our cell line models and those more affected in cancers with subunit upregulation, indicating that upregulations could be responsible for some of the phenotypes present in these patients.
Open AccessRNA Polymerase II subunits overexpressions induce genome instability and deregulate transcription
Independently of the pathways or circuits deregulated in cancer cells, these present altered transcription patterns, often also direct consequence of deregulation of transcription factors. In this sense, also the RNA Polymerase complexes responsible for transcription can be affected in cancers. We find that upregulations of RNA Polymerase II subunits, especially the largest ones, correlates with poor cancer patients’ outcome across a range of tumor types, presenting increased genome instability. Overexpressing the subunits RPB1, RPB3 and RPB4 in cells we find that these induce DNA damage. However, the mechanisms behind this increased genome instability are specific for each subunit, linked to the unique transcription alterations generated by the subunit overexpression. Importantly, we find significant overlap between the genes with more DNA damage in our cell line models and those more affected in cancers with subunit upregulation, indicating that upregulations could be responsible for some of the phenotypes present in these patients.
- Open Access
- 16 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
USP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication
Mammalian DNA replication relies on various DNA helicase and nuclease activities to ensure accurate genetic duplication, but how different helicase and nuclease activities are properly directed remains unclear. Here, we identify the ubiquitin-specific protease, USP50, as a chromatin-associated protein required to promote ongoing replication, fork restart, telomere maintenance, cellular survival following hydroxyurea or pyridostatin treatment, and suppression of DNA breaks near GC-rich sequences. We find that USP50 supports proper WRN-FEN1 localisation at or near stalled replication forks. Nascent DNA in cells lacking USP50 shows increased association of the DNA2 nuclease and RECQL4 and RECQL5 helicases and replication defects in cells lacking USP50, or FEN1 are driven by these proteins. Consequently, suppression of DNA2 or RECQL4/5 improves USP50-depleted cell resistance to agents inducing replicative stress and restores telomere stability. These data define an unexpected regulatory protein that promotes the balance of helicase and nuclease use at ongoing and stalled replication forks.
- 16 September 2024
- Published by Springer Nature in Nature Communications
- Vol. 15 (1) , 1-17
Open AccessUSP50 suppresses alternative RecQ helicase use and deleterious DNA2 activity during replication
Mammalian DNA replication relies on various DNA helicase and nuclease activities to ensure accurate genetic duplication, but how different helicase and nuclease activities are properly directed remains unclear. Here, we identify the ubiquitin-specific protease, USP50, as a chromatin-associated protein required to promote ongoing replication, fork restart, telomere maintenance, cellular survival following hydroxyurea or pyridostatin treatment, and suppression of DNA breaks near GC-rich sequences. We find that USP50 supports proper WRN-FEN1 localisation at or near stalled replication forks. Nascent DNA in cells lacking USP50 shows increased association of the DNA2 nuclease and RECQL4 and RECQL5 helicases and replication defects in cells lacking USP50, or FEN1 are driven by these proteins. Consequently, suppression of DNA2 or RECQL4/5 improves USP50-depleted cell resistance to agents inducing replicative stress and restores telomere stability. These data define an unexpected regulatory protein that promotes the balance of helicase and nuclease use at ongoing and stalled replication forks.
- Open Access
- 21 May 2024
- Published by Springer Nature in Genome Biology
- Vol. 25 (1) , 1-28
Genome-wide identification of replication fork stalling/pausing sites and the interplay between RNA Pol II transcription and DNA replication progression
Background: DNA replication progression can be affected by the presence of physical barriers like the RNA polymerases, leading to replication stress and DNA damage. Nonetheless, we do not know how transcription influences overall DNA replication progression. Results: To characterize sites where DNA replication forks stall and pause, we establish a genome-wide approach to identify them. This approach uses multiple timepoints during S-phase to identify replication fork/stalling hotspots as replication progresses through the genome. These sites are typically associated with increased DNA damage, overlapped with fragile sites and with breakpoints of rearrangements identified in cancers but do not overlap with replication origins. Overlaying these sites with a genome-wide analysis of RNA polymerase II transcription, we find that replication fork stalling/pausing sites inside genes are directly related to transcription progression and activity. Indeed, we find that slowing down transcription elongation slows down directly replication progression through genes. This indicates that transcription and replication can coexist over the same regions. Importantly, rearrangements found in cancers overlapping transcription-replication collision sites are detected in non-transformed cells and increase following treatment with ATM and ATR inhibitors. At the same time, we find instances where transcription activity favors replication progression because it reduces histone density. Conclusions: Altogether, our findings highlight how transcription and replication overlap during S-phase, with both positive and negative consequences for replication fork progression and genome stability by the coexistence of these two processes.
- 21 May 2024
- Published by Springer Nature in Genome Biology
- Vol. 25 (1) , 1-28
Open AccessGenome-wide identification of replication fork stalling/pausing sites and the interplay between RNA Pol II transcription and DNA replication progression
Background: DNA replication progression can be affected by the presence of physical barriers like the RNA polymerases, leading to replication stress and DNA damage. Nonetheless, we do not know how transcription influences overall DNA replication progression. Results: To characterize sites where DNA replication forks stall and pause, we establish a genome-wide approach to identify them. This approach uses multiple timepoints during S-phase to identify replication fork/stalling hotspots as replication progresses through the genome. These sites are typically associated with increased DNA damage, overlapped with fragile sites and with breakpoints of rearrangements identified in cancers but do not overlap with replication origins. Overlaying these sites with a genome-wide analysis of RNA polymerase II transcription, we find that replication fork stalling/pausing sites inside genes are directly related to transcription progression and activity. Indeed, we find that slowing down transcription elongation slows down directly replication progression through genes. This indicates that transcription and replication can coexist over the same regions. Importantly, rearrangements found in cancers overlapping transcription-replication collision sites are detected in non-transformed cells and increase following treatment with ATM and ATR inhibitors. At the same time, we find instances where transcription activity favors replication progression because it reduces histone density. Conclusions: Altogether, our findings highlight how transcription and replication overlap during S-phase, with both positive and negative consequences for replication fork progression and genome stability by the coexistence of these two processes.
- 10 April 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (5) , 670-671
Adding a transcription-coupled repair pathway
- 10 April 2024
- Published by Springer Nature in Nature Cell Biology
- Vol. 26 (5) , 670-671
Adding a transcription-coupled repair pathway
- Open Access
- 24 August 2023
- Published by MDPI AG in Applied Biosciences
- Vol. 2 (3) , 459-476
Deregulations of RNA Pol II Subunits in Cancer
Deregulated transcription is a well-known characteristic of cancer cells, with differentially expressed genes being a common feature of several cancers. Often, deregulated transcription is a consequence of alterations in transcription factors (TFs), which play a crucial role in gene expression and can act as tumour suppressors or proto-oncogenes. In eukaryotic organisms, transcription is carried out by three distinct RNA polymerase complexes: Pol I, Pol II, and Pol III. Pol II, specifically, is responsible for transcribing messenger RNA (mRNA), the protein coding part of the genome, as well as long non-coding RNAs (lncRNAs). While there is considerable research on the impact of specific deregulated transcription factors in cancer development, there is a lack of studies focusing on defects within the RNA polymerase complexes and their subunits. This review aims to shed light in particular on the Pol II complex and highlight the deregulation of its subunits that have a significant impact on tumour development, prognosis, and survival. By providing a comprehensive overview of our current understanding of Pol II subunits in cancer, this review emphasizes the importance of further research in this area. It suggests that exploring these subunits’ deregulations could lead to the identification of valuable biomarkers and potential therapeutic targets, making it a topic of collective interest.
- 24 August 2023
- Published by MDPI AG in Applied Biosciences
- Vol. 2 (3) , 459-476
Open AccessDeregulations of RNA Pol II Subunits in Cancer
Deregulated transcription is a well-known characteristic of cancer cells, with differentially expressed genes being a common feature of several cancers. Often, deregulated transcription is a consequence of alterations in transcription factors (TFs), which play a crucial role in gene expression and can act as tumour suppressors or proto-oncogenes. In eukaryotic organisms, transcription is carried out by three distinct RNA polymerase complexes: Pol I, Pol II, and Pol III. Pol II, specifically, is responsible for transcribing messenger RNA (mRNA), the protein coding part of the genome, as well as long non-coding RNAs (lncRNAs). While there is considerable research on the impact of specific deregulated transcription factors in cancer development, there is a lack of studies focusing on defects within the RNA polymerase complexes and their subunits. This review aims to shed light in particular on the Pol II complex and highlight the deregulation of its subunits that have a significant impact on tumour development, prognosis, and survival. By providing a comprehensive overview of our current understanding of Pol II subunits in cancer, this review emphasizes the importance of further research in this area. It suggests that exploring these subunits’ deregulations could lead to the identification of valuable biomarkers and potential therapeutic targets, making it a topic of collective interest.
- Open Access
- 4 July 2022
- Published by Wiley in The FEBS Journal
- Vol. 290 (18) , 4382-4394
RNAPII response to transcription‐blocking DNA lesions in mammalian cells
RNA polymerase II moves along genes to decode genetic information stored in the mammalian genome into messenger RNA and different forms of non‐coding RNA. However, the transcription process is frequently challenged by DNA lesions caused by exogenous and endogenous insults, among which helix‐distorting DNA lesions and double‐stranded DNA breaks are particularly harmful for cell survival. In response to such DNA damage, RNA polymerase II transcription is regulated both locally and globally by multi‐layer mechanisms, whereas transcription‐blocking lesions are repaired before transcription can recover. Failure in DNA damage repair will cause genome instability and cell death. Although recent studies have expanded our understanding of RNA polymerase II regulation confronting DNA lesions, it is still not always clear what the direct contribution of RNA polymerase II is in the DNA damage repair processes. In this review, we focus on how RNA polymerase II and transcription are both repressed by transcription stalling lesions such as DNA‐adducts and double strand breaks, as well as how they are actively regulated to support the cellular response to DNA damage and favour the repair of lesions.
- 4 July 2022
- Published by Wiley in The FEBS Journal
- Vol. 290 (18) , 4382-4394
Open AccessRNAPII response to transcription‐blocking DNA lesions in mammalian cells
RNA polymerase II moves along genes to decode genetic information stored in the mammalian genome into messenger RNA and different forms of non‐coding RNA. However, the transcription process is frequently challenged by DNA lesions caused by exogenous and endogenous insults, among which helix‐distorting DNA lesions and double‐stranded DNA breaks are particularly harmful for cell survival. In response to such DNA damage, RNA polymerase II transcription is regulated both locally and globally by multi‐layer mechanisms, whereas transcription‐blocking lesions are repaired before transcription can recover. Failure in DNA damage repair will cause genome instability and cell death. Although recent studies have expanded our understanding of RNA polymerase II regulation confronting DNA lesions, it is still not always clear what the direct contribution of RNA polymerase II is in the DNA damage repair processes. In this review, we focus on how RNA polymerase II and transcription are both repressed by transcription stalling lesions such as DNA‐adducts and double strand breaks, as well as how they are actively regulated to support the cellular response to DNA damage and favour the repair of lesions.
- Open Access
Transcription–Replication Coordination
Transcription and replication are the two most essential processes that a cell does with its DNA: they allow cells to express the genomic content that is required for their functions and to create a perfect copy of this genomic information to pass on to the daughter cells. Nevertheless, these two processes are in a constant ambivalent relationship. When transcription and replication occupy the same regions, there is the possibility of conflicts between transcription and replication as transcription can impair DNA replication progression leading to increased DNA damage. Nevertheless, DNA replication origins are preferentially located in open chromatin next to actively transcribed regions, meaning that the possibility of conflicts is potentially an accepted incident for cells. Data in the literature point both towards the existence or not of coordination between these two processes to avoid the danger of collisions. Several reviews have been published on transcription–replication conflicts, but we focus here on the most recent findings that relate to how these two processes are coordinated in eukaryotes, considering advantages and disadvantages from coordination, how likely conflicts are at any given time, and which are their potential hotspots in the genome.
Open AccessTranscription–Replication Coordination
Transcription and replication are the two most essential processes that a cell does with its DNA: they allow cells to express the genomic content that is required for their functions and to create a perfect copy of this genomic information to pass on to the daughter cells. Nevertheless, these two processes are in a constant ambivalent relationship. When transcription and replication occupy the same regions, there is the possibility of conflicts between transcription and replication as transcription can impair DNA replication progression leading to increased DNA damage. Nevertheless, DNA replication origins are preferentially located in open chromatin next to actively transcribed regions, meaning that the possibility of conflicts is potentially an accepted incident for cells. Data in the literature point both towards the existence or not of coordination between these two processes to avoid the danger of collisions. Several reviews have been published on transcription–replication conflicts, but we focus here on the most recent findings that relate to how these two processes are coordinated in eukaryotes, considering advantages and disadvantages from coordination, how likely conflicts are at any given time, and which are their potential hotspots in the genome.